Large enhancement of radiative strength for soft transisitons in the quasicontinuum

Radiative strength functions (RSFs) for the 56,57-Fe nuclei below the separation energy are obtained from the 57-Fe(3-He,alpha gamma)56-Fe and 57-Fe(3-He,3-He' gamma)57-Fe reactions, respectively. An enhancement of more than a factor of ten over common theoretical models of the soft (E_gamma ~< 2 MeV) RSF for transitions in the quasicontinuum (several MeV above the yrast line) is observed. Two-step cascade intensities with soft primary transitions from the 56-Fe(n,2gamma)57-Fe reaction confirm the enhancement.Comment: 4 pages including 3 figure

Partial level density of the n-quasiparticle excitations in the nuclei of the 39< A <201 region

Level density and radiative strength functions are obtained from the analysis of two-step cascades intensities following the thermal neutrons capture. The data on level density are approximated by the sum of the partial level densities corresponding to n quasiparticles excitation. The most probable values of the collective enhancement factor of the level density are found together with the thresholds of the next Cooper nucleons pair breaking. These data allow one to calculate the level density of practically any nucleus in given spin window in the framework of model concepts, taking into account all known nuclear excitation types. The presence of an approximation results discrepancy with theoretical statements specifies the necessity of rather essentially developing the level density models. It also indicates the possibilities to obtain the essentially new information on nucleon correlation functions of the excited nucleus from the experiment.Comment: 29 pages, 8 figures, 2 table

Sudesna mjerenja γγ-raspada stanja 166Ho nastalih reakcijom (n,γ)

Levels of 166Ho were studied using thermal and average resonance neutron capture and with the (d,p) and (d,3He) reactions. We have devoted a large effort to the measurements of the γγ-coincidence spectra in the broad energy region 50 - 6243 keV. Based on these data and those of earlier studies, the levels are grouped into 23 rotational bands. Among them are 6 new ones. The results are in good agreement with the semiempirical and quasiparticle-phonon model, where Coriolis and residual interactions are taken into account. Details of model interpretation have been presented in a previously published paper.Proučavali smo stanja 166Ho nastala termičkim i prosječnim rezonantnim uhvatom neutrona, te (d,p) i (d,3He) reakcijama. Uložili smo velik trud u mjerenjima sudesnih γγ-spektara u širokom energijskom području od 50 do 6243 keV. Na osnovi tih i ranijih podataka, stanja su grupirana u 23 rotacijske vrpce. Među njima je i 6 novih. Ishodi su u suglasju s poluempiričkim i kvazičestično-fononskim modelom, uzimajući u obzir Coriolisovo međudjelovanje i rezidualne interakcije. Podrobnosti modelskog tumačenja objavljene u u ranijem članku

Sudesna mjerenja γγ-raspada stanja 166Ho nastalih reakcijom (n,γ)

Levels of 166Ho were studied using thermal and average resonance neutron capture and with the (d,p) and (d,3He) reactions. We have devoted a large effort to the measurements of the γγ-coincidence spectra in the broad energy region 50 - 6243 keV. Based on these data and those of earlier studies, the levels are grouped into 23 rotational bands. Among them are 6 new ones. The results are in good agreement with the semiempirical and quasiparticle-phonon model, where Coriolis and residual interactions are taken into account. Details of model interpretation have been presented in a previously published paper.Proučavali smo stanja 166Ho nastala termičkim i prosječnim rezonantnim uhvatom neutrona, te (d,p) i (d,3He) reakcijama. Uložili smo velik trud u mjerenjima sudesnih γγ-spektara u širokom energijskom području od 50 do 6243 keV. Na osnovi tih i ranijih podataka, stanja su grupirana u 23 rotacijske vrpce. Među njima je i 6 novih. Ishodi su u suglasju s poluempiričkim i kvazičestično-fononskim modelom, uzimajući u obzir Coriolisovo međudjelovanje i rezidualne interakcije. Podrobnosti modelskog tumačenja objavljene u u ranijem članku

Endometriosis as a Comorbid Condition in Chronic Fatigue Syndrome (CFS): Secondary Analysis of Data From a CFS Case-Control Study

Background: Endometriosis (EM) is a recognized co-morbid condition in women with chronic fatigue syndrome (CFS). This analysis evaluates the impact of EM on the health of women with CFS by comparing selected health characteristics and laboratory parameters in women with CFS with and without EM (CFS+EM and CFS-only).Methods: This secondary analysis included all 36 women with CFS from a cross-sectional study of CFS in Wichita, KS, conducted between 2002 and 2003. The health characteristics and laboratory parameters of interest included functioning, fatigue, CFS-related symptoms, gynecologic history, routine laboratory parameters, inflammatory markers, cortisol levels, allostatic load, and sleep parameters (overnight polysomnography). We used parametric or non-parametric tests to compare group differences in the selected health characteristics and laboratory parameters. For examining the association between EM and variables of interest, logistic regression models were performed and odds ratios (OR) with 95% confidence intervals (CI) were reported for the magnitude of associations. Statistical significance was set at 0.05 (two-sided).Results: The mean age of this study sample was 50.9 years. Of women with CFS, 36.1% reported having EM. Age and body mass index (BMI) did not differ between CFS+EM and CFS-only groups. When examining the impact of EM, compared to women with CFS-only, women with both CFS and EM were more likely to report chronic pelvic pain [OR = 9.00 (95% CI, 1.47–55.25)] and hysterectomy [OR = 10.3 (1.82–58.39)], had more CFS symptoms (6.8 ± 0.3 vs. 5.5 ± 0.3, p = 0.02), younger mean age at menopause onset (36.4 ± 3.0 vs. 47.0 ± 2.7 years, p = 0.03), higher mean number of obstructive apnea episodes per hour (20.3 vs. 4.4, p = 0.05) and reported more negative life events (15.8 vs. 4.4, p = 0.05). Other parameters did not differ significantly between the two groups.Conclusions: We found more than a third of women with CFS reported endometriosis as a comorbid condition. The endometriosis comorbidity was associated with chronic pelvic pain, earlier menopause, hysterectomy, and more CFS-related symptoms. However, endometriosis in women with CFS did not appear to further impact functioning, fatigue, inflammatory markers, or other laboratory parameters. Further investigations including younger women are warranted

Regular Matching and Inclusion on Compressed Tree Patterns with Context Variables

International audienceWe study the complexity of regular matching and inclusion for compressed tree patterns extended by context variables. The addition of context variables to tree patterns permits us to properly capture compressed string patterns but also compressed patterns for unranked trees with tree and hedge variables. Regular inclusion for the latter is relevant to certain query answering on Xml streams with references

Complementary and alternative medical therapy utilization by people with chronic fatiguing illnesses in the United States

<p>Abstract</p> <p>Background</p> <p>Chronic fatiguing illnesses, including chronic fatigue syndrome (CFS), pose a diagnostic and therapeutic challenge. Previous clinical reports addressed the utilization of health care provided to patients with CFS by a variety of practitioners with other than allopathic training, but did not examine the spectrum of complementary and alternative medicine (CAM) therapies used. This study was designed to measure CAM therapy use by persons with fatiguing illnesses in the United States population.</p> <p>Methods</p> <p>During a random-digit dialing survey to estimate the prevalence of CFS-like illness in urban and rural populations from different geographic regions of the United States, we queried the utilization of CAM including manipulation or body-based therapies, alternative medical systems, mind-body, biologically-based, and energy modalities.</p> <p>Results</p> <p>Four hundred forty fatigued and 444 non-fatigued persons from 2,728 households completed screening. Fatigued subjects included 53 persons with prolonged fatigue, 338 with chronic fatigue, and 49 with CFS-like illness. Mind-body therapy (primarily personal prayer and prayer by others) was the most frequently used CAM across all groups. Among women, there was a significant trend of increasing overall CAM use across all subgroups (p-trend = 0.003). All categories of CAM use were associated with significantly poorer physical health scores, and all but one (alternative medicine systems) were associated with significantly poorer mental health scores. People with CFS-like illness were significantly more likely to use body-based therapy (chiropractic and massage) than non-fatigued participants (OR = 2.52, CI = 1.32, 4.82). Use of body-based therapies increased significantly in a linear trend across subgroups of non-fatigued, prolonged fatigued, chronic fatigued, and CFS-like subjects (p-trend = 0.002). People with chronic fatigue were also significantly more likely to use body-based therapy (OR = 1.52, CI = 1.07, 2.16) and mind-body (excluding prayer) therapy than non-fatigued participants (OR = 1.73, CI = 1.20 – 2.48).</p> <p>Conclusion</p> <p>Utilization of CAM was common in fatiguing illnesses, and was largely accounted for by the presence of underlying conditions and poor physical and mental health. Compared to non-fatigued persons, those with CFS-like illness or chronic fatigue were most likely to use body-based and mind-body therapies. These observations have important implications for provider education programs and development of intervention strategies for CFS.</p

Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in Georgia

<p>Abstract</p> <p>Background</p> <p>Chronic fatigue syndrome (CFS) is a debilitating condition of unknown etiology and no definitive pharmacotherapy. Patients are usually prescribed symptomatic treatment or self-medicate. We evaluated prescription and non-prescription drug use among persons with CFS in Georgia and compared it to that in non-fatigued <it>Well </it>controls and also to chronically <it>Unwell </it>individuals not fully meeting criteria for CFS.</p> <p>Methods</p> <p>A population-based, case-control study. To identify persons with possible CFS-like illness and controls, we conducted a random-digit dialing telephone screening of 19,807 Georgia residents, followed by a detailed telephone interview of 5,630 to identify subjects with CFS-like illness, other chronically <it>Unwell</it>, and <it>Well </it>subjects. All those with CFS-like illness (n = 469), a random sample of chronically <it>Unwell </it>subjects (n = 505), and <it>Well </it>individuals (n = 641) who were age-, sex-, race-, and geographically matched to those with CFS-like illness were invited for a clinical evaluation and 783 participated (48% overall response rate). Clinical evaluation identified 113 persons with CFS, 264 <it>Unwell </it>subjects with insufficient symptoms for CFS (named ISF), and 124 <it>Well </it>controls; the remaining 280 subjects had exclusionary medical or psychiatric conditions, and 2 subjects could not be classified. Subjects were asked to bring all medications taken in the past 2 weeks to the clinic where a research nurse viewed and recorded the name and the dose of each medication.</p> <p>Results</p> <p>More than 90% of persons with CFS used at least one drug or supplement within the preceding two weeks. Among users, people with CFS used an average of 5.8 drugs or supplements, compared to 4.1 by ISF and 3.7 by <it>Well </it>controls. Persons with CFS were significantly more likely to use antidepressants, sedatives, muscle relaxants, and anti-acids than either <it>Well </it>controls or the ISF group. In addition, persons with CFS were significantly more likely to use pain-relievers, anti-histamines and cold/sinus medications than were <it>Well </it>controls.</p> <p>Conclusion</p> <p>Medical care providers of patients with chronic fatigue syndrome should be aware of polypharmacy as a problem in such patients, and the related potential iatrogenic effects and drug interactions.</p